2
Clinical Trials associated with BM-201Clinical study on the safety, tolerability, and preliminary efficacy of BM201 injection combined with radiation therapy and PD-1 monoclonal antibody in patients with advanced solid tumors
Start Date30 Nov 2023 |
Sponsor / Collaborator- |
The Study to Evaluate the Safety, PK, and Preliminary Efficacy of BM201 Injection Combined With Radiotherapy in Patients With Unresectable Locally Advanced or Metastatic Solid Tumors That Failed Standard Therapy
This is a non-randomized,open-label,controlled multi-center Phase Ⅰ study to evaluate tolerability, pharmacokinetics, and preliminary efficacy of BM201 injection in combination with radiotherapy in patients with histologically or cytologically confirmed unresectable locally advanced or metastatic solid tumors who have failed standard therapy or are unable to receive standard treatment.
Start Date07 Nov 2022 |
Sponsor / Collaborator- |
100 Clinical Results associated with BM-201
100 Translational Medicine associated with BM-201
100 Patents (Medical) associated with BM-201
100 Deals associated with BM-201